← Leaderboards
Lawrence Thomas Kim
University Of Texas Sw Med Ctr/Dallas
$1,061,174
Attributed
$2,067,196
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $522.4K · FY2021–24$1M$750K$500K$250K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$2,067,196 · 2
By mechanism
R01$2,012,045 · 1
P30$55,151 · 1
Top collaborators
- Zhanhong Wu4 shared
Most similar at University Of Texas Sw Med Ctr/Dallas
Same institution · by research overlap
- Fangming Lin$5,208,556
- Naim M Maalouf$8,442,081
- Khashayar Sakhaee$14,492,169
- Orson W Moe$15,748,560
- W Matthew Petroll$12,265,086
Research focus
G-Protein-Coupled ReceptorsHyperparathyroidismAreaFluorophoreAdenomaHydrogen BondingCalciumCalcium-Sensing ReceptorsFluorescence-Guided SurgeryFluorescent DyesCellsCinacalcetGlandDesignDetectionDissectionDyesEnsureAffectFluorescenceEvaluationExcisionExtracellularImage
Grant awards (5)
The development of novel PET/NIRF agents for hyperparathyroidism management$474,920
R01 · FY2024 · DK
The development of novel PET/NIRF agents for hyperparathyroidism management$522,433
R01 · FY2023 · DK
The development of novel PET/NIRF agents for hyperparathyroidism management$507,373
R01 · FY2022 · DK
The development of novel PET/NIRF agents for hyperparathyroidism management$507,319
R01 · FY2021 · DK
Role of FAK in keratinocyte adhesion$55,151
P30 · FY2000 · AR